NREP
NEW REPRESENTATIVE AT IB RECEIVED
05/07/2026
Back to search
Official data from USPTO
FACTORI
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
FACTORI
ST13
US500000079363629Class
7, 9, 10, 19, 37, 40, 42, 44
Filing
79363629
Registration
7539778
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
48
Latest update
05/08/2026
Trademark type
Word
Nice classes
7, 9, 10, 19, 37, 40, 42, 44
Filing date
08/05/2022
Registration date
10/22/2024
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
10/22/2024
Last transaction
05/08/2026
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Drawing code
4
Owner type
99
Owner location
GB
Examiner
HARDY LUDLOW, TARAH KIM
Law office
M10
Current location
FILE REPOSITORY (FRANCONIA)
Holders and representatives
Holders
Oribiotech Limited
Representatives
Maury M. Tepper, III Tepper & Eyster, PLLC
Technical classification
Nice Classes
Class 7Class 9Class 10Class 19Class 37Class 40Class 42Class 44
Vienna Codes
No Vienna codes available.
Goods and services
Class 7
Machines and manufacturing equipment for cell and gene therapiesmachines for manufacturing biopharmaceuticals used for cell culturecell therapy and gene therapy; components of machines for manufacturing biopharmaceuticals used for cell culturecell therapy and gene therapy in the nature of racks for holding cell and gene therapy manufacturing equipment; bioreactors for use in manufacturing biopharmaceuticals including cassettes for industrial bioreactors sold as a unit; bioreactors for use in manufacturing biopharmaceuticals including disposable cassettes for industrial bioreactors sold as a unit; partsincluding disposable parts for industrial manufacturing equipment for use in manufacturing biopharmaceuticals in cell and gene therapiessterile connectors for industrial manufacturing apparatus for cell and gene therapy; bellows being containers as parts of machines for storingcontainingdispensing or extracting fluidsstem cellscell cultures or cell culture media to or from industrial manufacturing apparatus and equipment; machines and manufacturing equipment for cell and gene therapiesmachines for use in manufacturing biopharmaceuticals used for cell culturecell therapy and gene therapy; industrial bioreactors for use in manufacturing biopharmaceuticalsparts of industrial bioreactors for use in manufacturing biopharmaceuticalsbellowscassettesracks and connectors sold as part of a transportable mobile unit or transportable building
Class 9
Laboratory apparatus and equipment for cell therapy and gene therapycell culture hoodsbio-safety cabinetswater bathscell culture vessels; parts of laboratory apparatus in the nature of bioreactors for gene therapybellowsconnectorsflexible containers for storingcontainingdispensing or extracting fluidsstem cellscell cultures or cell culture media sold as part of a transportable mobile unit or transportable building
Class 10
Medical apparatus and equipmentpatient monitors for critical care and anesthesiaanesthesia machinesmedical imaging apparatusessurgical instruments; IV apparatusintravenous (IV) standsintravenous (IV) infusion pumpsintravenous (IV) infusion sets; machines in the nature of medical apparatus and instruments for delivering cell and gene therapies to patientsmedical syringesinjection sets in the nature of syringes and needlesinfusion setscatheterscannulas; IV drips in the nature of intravenous bags sold empty for intravenous therapy; cell bags in the nature of intravenous bags sold empty for intravenous cell therapy; bags for collecting blood and fluids from humans or animals for medical purposes; patient side cell therapy and gene therapy machines in the nature of medical apparatus and instrumentsincubatorscell culture apparatuses in the nature of cell culture chambers; medical apparatus and instruments for cell and gene therapyintravenous bags sold empty for intravenous therapy; parts of medical apparatus and instruments for cell and gene therapyintravenous (IV) standsintravenous (IV) infusion pumpsintravenous (IV) infusion sets sold as part of a transportable mobile unit or transportable building
Class 19
pre-fabricated laboratories in the nature of prefabricated non-metal buildings for use as medical laboratories and not for use in manufacturing
Class 37
Installationrepairmaintenancecleaning of bioreactorsscientific and manufacturing equipment
Class 40
Custom manufacturing of cell therapy and gene therapy products for othersbioreactorsparts of bioreactorsfiling machines for bioreactors; custom cell and gene therapy manufacturing for others
Class 42
Scientific researchdesign and development services for others in biotechnology; pharmaceutical product design and development of cell therapy products for others; pharmaceutical product development of cell and gene therapy processes for others; technological research consultancy in relation to cell and gene therapy and cell and gene therapy manufacturing processes; rental of scientific laboratory apparatusequipment and instruments; rental of laboratory apparatus and instruments for cell therapy and gene therapy in the nature of rental of bioreactors and partsfittings and accessories for bioreactors
Class 44
Medical services featuring cell and gene therapies delivered to patients; medical treatment services; rental of medical apparatus and instruments for cell and gene therapy
Publications
History of USPTO decisions and trademark events.
48 publications found
NREP
NEW REPRESENTATIVE AT IB RECEIVED
11/29/2025
FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
04/12/2025
FICS
FINAL DISPOSITION NOTICE SENT TO IB
03/25/2025
FIMP
FINAL DISPOSITION PROCESSED
03/25/2025
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
01/22/2025
NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
10/22/2024
R.PR
REGISTERED-PRINCIPAL REGISTER
10/22/2024
OPNX
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
08/11/2024
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
08/06/2024
PUBO
PUBLISHED FOR OPPOSITION
08/06/2024
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
07/22/2024
OPNR
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
07/21/2024
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
07/17/2024
EXPT
EXPARTE APPEAL TERMINATED
06/27/2024
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
06/27/2024
XAEC
EXAMINER'S AMENDMENT ENTERED
06/27/2024
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
06/27/2024
GNEA
EXAMINERS AMENDMENT E-MAILED
06/27/2024
CNEA
EXAMINERS AMENDMENT -WRITTEN
06/27/2024
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
06/26/2024
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
06/26/2024
ALIE
ASSIGNED TO LIE
06/25/2024
ERFR
TEAS REQUEST FOR RECONSIDERATION RECEIVED
06/25/2024
EXPI
EX PARTE APPEAL-INSTITUTED
06/25/2024
JURT
JURISDICTION RESTORED TO EXAMINING ATTORNEY
06/25/2024
EXAF
EXPARTE APPEAL RECEIVED AT TTAB
06/25/2024
ADCH
CHANGE OF NAME/ADDRESS REC'D FROM IB
02/16/2024
GNFN
NOTIFICATION OF FINAL REFUSAL EMAILED
01/05/2024
GNFR
FINAL REFUSAL E-MAILED
01/05/2024
CNFR
FINAL REFUSAL WRITTEN
01/05/2024
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
01/04/2024
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
01/04/2024
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
01/04/2024
RFNT
REFUSAL PROCESSED BY IB
08/01/2023
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
07/07/2023
RFRR
REFUSAL PROCESSED BY MPU
07/07/2023
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
05/25/2023
CNRT
NON-FINAL ACTION WRITTEN
05/24/2023
DOCK
ASSIGNED TO EXAMINER
05/24/2023
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
04/14/2023
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
04/14/2023
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
04/14/2023
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
04/14/2023
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
04/14/2023
MAFR
APPLICATION FILING RECEIPT MAILED
02/28/2023
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
02/24/2023
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
02/23/2023
Continuous trademark protection
Get notified about every new filing that threatens FACTORI or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.